Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

BSP Exam I > Study Design > Flashcards

Study Design Flashcards

1
Q

2 broad types of quantitative study design

A

Interventional = forced allocation into study groups (RANDOMIZED)

Observational = no forced allocation to study groups (RANDOMLY SELECTED)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

5 types of interventional studies in order of increasing strength of evidence

A 
Phase 0
Phase 1
Phase 2
Phase 3
Phase 4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

5 types of observational studies in order of increasing strength of evidence

A 
Case reports/series
Ecological
Cross-sectional
Case-control
Cohort
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a null hypothesis (H0)?

A

Research perspective which states there will be no (true) difference between the groups being compared

[contrast with alternative hypothesis (H1) — states there will be a true difference between the groups being compared]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 3 statistical perspectives taken in interventional studies regarding the null hypothesis?

A

Superiority (ex: trying to prove one drug is better than another, or better than placebo)

Noninferiority (ex: trying to prove one drug is not worse than another)

Equivalency (ex: trying to prove one drug is equivalent to another)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Prospective vs. retrospective vs. ambidirectional

A

Prospective — outcome not yet known

Retrospective — outcome is already known

Ambidirectional — first looking retrospectively, then looking prospectively for additional outcome occurrences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What interventional and observational studies can be done in a prospective fashion?

A

Interventional — phases 0-4

Observational — only cohort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

________ validity = generalizability/applicability of acquired information to non-study patients

_______ validity = validity of acquired information based on study methods

A

External

Internal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2 key questions to selecting the correct study design

A
  1. Is researcher allocating to forced intervention? (Yes=interventional, no=observational)
  2. For observational studies, how were groups organized? (Disease status, exposure status, common factor, large pop.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Observational study design in which groups are organized by disease status

A

Case-control/nested case-control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Observational study design in which groups are organized by exposure status

A

Cohort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Observational study design in which groups are organized together due to a “common factor”

A

Cohort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Observational study design in which groups are organized based on data collected across large population

A

Cross-sectional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Useful study design when studying a rare disease; commonly generates an odds of exposure for each, then an odds ratio as the measure of association

A

Case-control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Case-control studies are customarily conducted in a _______ fashion

A

Retrospective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Strengths of case-control studies

A

Useful when diseases have low occurrence

Useful in determining associations (NOT causation)

Good for assessing multiple exposures of one outcome

Useful when disease has a long induction/latent period

Good when ethical issues limit use of interventional studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Type of case-control studies derived out of, or conducted after, a prospective previous (or ongoing) study-type (often cohort or interventional study)

A

Nested case control study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Study design useful when studying a rare exposure; commonly generates the risk of disease/outcome for each, then a risk ratio/relative risk as a measure of association

A

Cohort study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

T/F: a cohort study may not always describe how groups are allocated

A

True

[once cohort is selected, can divide based on exposure OR disease/outcome]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Strengths of cohort studies

A

Useful when exposures have low occurrence

Useful when you have a group of study subjects that can be studied to answer numerous research questions

Useful in determining associations (NOT causation)

Good for assessing multiple outcomes of one exposure

Can be conducted ambidirectional

Good for long induction/latent periods (retrospective)

Able to represent temporality (prospective)

Good when ethical issues limit use of interventional studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Observational studies that capture health/disease and exposure statuses in a large population at the same time; aka PREVALENCE study

A

Cross-sectional

[information gathered represents what is occurring at a point in time/time-frame across a large population, acquired without regard to exposure or disease/outcome status]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Focuses simultaneously on disease and population characteristics, including exposures, health status, health-care utilization, etc; seeks associations (NOT causation), generatese and tests hypotheses (possible associations), and by repetition in different time periods, can be used to measure change/trends (not in same pts)

A

Cross-sectional studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Many _______ studies are large-scale, national surveys or databases capturing different aspects of the ‘population’

A

Cross sectional

24
Q

The Framingham Heart Study and the Nurses Health Study are examples of …

A

Cohort studies

25
Q

NHANES and NCHS are examples of _____ studies

A

Cross sectional

[NHANES is National Health and Nutrition Examination Survey, NCHS is National Center for Health Statistics…if it has the word NATIONAL in it — likely a cross sectional]

26
Q

Purpose/focus, population studied, sample size, and duration of a phase 0 interventional study

A

Assess drug-target actions and pharmacokinetics in non-therapeutic/non-diagnostic doses (first-in-human use)

Healthy (or diseased patients (oncology)) volunteers

Very small N (e.g., <20)

Very short duration (e.g., a single dose to just a few days)

27
Q

Purpose/focus, population studied, sample size, and duration of a phase 1 interventional study

A

Assess safety/tolerance and pharmacokinetics of one or more dosages (first-/early-in-human use)

Healthy or disease volunteers (depends on disease)

Small N (e.g., 20-80)

Short duration (e.g., several days to a few weeks)

28
Q

Purpose/focus, population studied, sample size, and duration of a phase 2 interventional study

A

Assess effectiveness (continues to assess safety/tolerability; expands on Phase 1 purpose)

Diseased volunteers (may have narrow inclusion criteria for isolation of effects)

Larger N (e.g., a few to several hundred)

Short-to-medium duration (e.g., a few weeks to a few months)

29
Q

Purpose/focus, population studied, sample size, and duration of a phase 3 interventional study

A

Assess effectiveness (continues to assess safety/tolerability)

Diseased volunteers (may expand inclusion criteria and comparison group(s) for delineation of effects; may take superiority, noninferiority, equivalency perspective)

Larger N (e.g., several hundred to a few thousand)

Longer duration (e.g., a few months to a year+)

30
Q

Purpose/focus, population studied, sample size, and duration of a phase 4 interventional study

A

Assess long-term safety, effectiveness, optimal use (risk/benefits)

Diseased volunteers (expand use criteria for delineation of long-term safety/effects)

Larger (population) N (e.g., a few hundred to tens-of-thousands)

Longer, wide-range durations (e.g., many months to several years; ongoing)

31
Q

Last phase of interventional studies before drug goes on the market

A

Phase 3

32
Q

Subjects randomly allocated once into a single treatment group; no further randomizations into sub-treatment groups

A. Simple
B. Factorial
C. Parallel
D. Cross-over
E. Pragmatic
A

A. Simple

33
Q

Subjects randomly allocated into an initial group, then further randomly-divided into sub-group (i.e., multiple randomizations

A. Simple
B. Factorial
C. Parallel
D. Cross-over
E. Pragmatic
A

B. Factorial

34
Q

Useful in testing multiple hypotheses at the same time because increases sample size requirement

A. Simple
B. Factorial
C. Parallel
D. Cross-over
E. Pragmatic
A

B. Factorial

35
Q

Subjects simultaneously yet exclusively managed in a single treatment group, with NO switching of groups after initial randomization

A. Simple
B. Factorial
C. Parallel
D. Cross-over
E. Pragmatic
A

C. Parallel

36
Q

Subjects forcibly switched to other treatment group after initial treatment assignment; between- and within-group comparisons possible; must differentiate wash-out vs. lead-in

A. Simple
B. Factorial
C. Parallel
D. Cross-over
E. Pragmatic
A

D. Cross-over

37
Q

Wash-out vs. lead-in

A

Wash-out = clear effects of previous group; seen in cross-over studies

Lead-in = a wash-out period prior to starting a study (e.g., stop current med before starting study on a new med)

38
Q

Traditional interventional studies are limited/restrictive in terms of group allocation and criteria. What type of INTERVENTIONAL study allows more flexibility so that physicians can alter dosages, add treatments, etc. to best manage the patient/disease?

A

Pragmatic interventional studies

39
Q

______ group allocation procedure most commonly utilized; subjects have equal probability of being assigned to each of the pre-defined intervention groups

A

Random

[contrast with non-random = some investigator-developed way to select patients]

40
Q

______ randomization = equal probability for allocation into one of the study groups

A

Simple

41
Q

_____ randomization = ensures balance within each intervention group [when researchers want to assure that all groups are equal in size]

A

Blocked

42
Q

_____ randomization = ensures balance within known confounding variables (i.e., gender, age, disease severity); can also pre-select levels to be balanced within each interfering factor (confounder)

A

Stratified

43
Q

Inert tx made to look identical in all aspects to active tx

A

Placebo (dummy therapy)

[double-dummy = more than 1 placebo used]

44
Q

Improvement in condition by power of suggestion of being treated

A

Placebo-effect

45
Q

Study subjects change their behavior solely due to awareness of being studied/observed

A

Hawthorne-effect

46
Q

Ethical conduct of research guided by _____ ______; contains key guiding principles — respect for persons (research voluntary, subjects autonomous), beneficence (risks are justified by potential benefits), justice (risks and benefits are equally distributed)

A

Belmont report

47
Q

Consent vs. assent

A

Consent = agreement to participate, based on being fully and completely informed, given by mentally-capable individuals of legal consenting age (i.e., adults, age 18 in most states)

Assent = agreement to participate, based on being fully and completely informed, given by mentally-capable individuals NOT able to give legal consent

48
Q

3 types of masking/blinding in interventional studies

A

Single-blind — subjects are not informed which group they’re in, but investigators know

Double-blind — neither investigators nor study subjects know which intervention/treatment group they’re in

Open-label — both investigators and study subjects know

49
Q

Procedure for assessing placebo-effect and hawthorne-effect, as well as compliance, before a study begins

A

Run-in or lead-in phase

Subjects can be give placebo for initial pre-study time frame to determine new baseline of disease; can assess study protocol compliance before actual protocol begins

50
Q

Group whose role it is to protect human subjects from undue risk; all human studies must be reviewed by them PRIOR to study starting

A

IRB

51
Q

______ = genuine confidence that an intervention/tx may be worthwhile (risk vs. benefit) in order to use it in humans

A

Equipoise

52
Q

Level of IRB review used for all interventional (clinical) trials; more than low-to-minimal risk

A

Full board

53
Q

Level of IRB review used for low-to-minimal risk studies; no patient identifiers

A

Expedited

54
Q

Level of IRB review used for chart review or existing samples/data with no patient identifiers, no risk, environmental (community-site) studies

A

Exempt

55
Q

Semi-independent committee not involved with conduct of study but charged with reviewing data as the study progresses to assess for undue risk or benefit; can stop the study early

A

Data Safety and Monitoring Board (DSMB)

56
Q

2 ways of managing drop-outs/lost-to-follow-up

A

Include them — intent to treat [most conservative]; use last known assessment, or use baseline measurements. Preserves randomization process, maintains statistical power

Exclude them — per protocol [aka efficacy analysis]; must meet pre-established level of compliance/participation to be included. Biases estimates of effect and can limit generalizability

57
Q

2 major advantages to interventional study designs

A

Cause precedes effect (can demonstrate causation)

These are the only designs used for “approval” process (on-label)

BSP Exam I (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions